The medical robot industry has evolved into a new development phase, as more corner-stone investors have joined the supporting group.
MicroPort Medical recently closed a financing deal of CNY 3 billion in cooperation with a series of strategic investors, including Hillhouse Capital, CPE, GF Investment and E Fund. The investment will help popularize MicroPort’s medical robots and further expand market exposure.
After the financing deal, the company will be valued at CNY 22.5 billion and will still be the subsidiary company of MicroPort Holding Group. This year, MicroPort CardioFlow Meditech raised USD 130 million. The company’s orthopedics segment was financed with CNY 580 million, the cardiac rhythm management received USD 105 million, and the subsidiary Horizon Medical CNY 130 million and the EP MedTech CNY 300 million.